- ISSN: 0253-8253
- EISSN: 2227-0426
-
oa Selected Abstracts From Other Journals
- Source: Qatar Medical Journal, Volume 2006, Issue 1, Jun 2006, 25
-
- 01 June 2006
Abstract
Background: A consensus has emerged that angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) have specific renoprotective effects. Guidelines specify that these are the drugs of choice for the treatment of hypertension in patients with renal disease. We sought to determine to what extent this consensus is supported by the available evidence.
© 2006 Hammoudeh, Gehani, licensee Bloomsbury Qatar Foundation Journals.
